By Sam Michael
Indian manufacturers looking to export medical devices from India in 2026 are stepping into one of the strongest windows of opportunity in years. Rising global demand, maturing government support through the PLI scheme, and growing interest from U.S. buyers seeking reliable, cost-effective supply chains are creating real momentum. Success depends on mastering CDSCO compliance, achieving ISO 13485 certification, and meeting strict U.S. FDA requirements from the start.
India’s medical device sector exported roughly $4.1 billion worth of products in FY25 while still importing $8.6 billion. The government’s goal of reaching $50 billion in sector value by 2030 is driving fresh investment. For American hospitals, clinics, and distributors, Indian manufacturers offer competitive pricing on consumables, surgical instruments, diagnostic kits, and an expanding range of higher-value equipment. This helps U.S. healthcare providers manage costs and reduce over-reliance on any single overseas source.
Here’s exactly how manufacturers can navigate the process in 2026.
Step 1: Lock Down Indian Regulatory Compliance First
Classify your device correctly under the Medical Device Rules, 2017 (Class A–D based on risk). Lower-risk devices often move through State Licensing Authorities, while higher-risk Class C and D products require deeper CDSCO review. Secure the right manufacturing license and prepare your Device Master File (DMF) and Plant Master File (PMF).
These documents prove your facility meets Indian standards and give international buyers immediate confidence. Many U.S. importers now ask for CDSCO license copies during initial qualification.
Step 2: Build a Strong Quality Management System
ISO 13485 certification has become the baseline expectation for serious exporters. It shows you can consistently design, manufacture, and support safe devices. Pair it with risk management practices aligned to ISO 14971.
U.S. FDA investigators and European notified bodies look for this level of control. Manufacturers who invest early in robust QMS avoid costly rework later and win more contracts.
Step 3: Prepare Complete Technical Documentation
Create a thorough Technical File or Design Dossier. Include clinical or performance evaluation data, manufacturing process controls, and clear labeling/Instructions for Use. For U.S.-bound products, align documentation with what FDA reviewers expect under 21 CFR.
Strong files speed up buyer audits and regulatory clearances. Keep everything traceable and up to date.
Step 4: Meet U.S. Market Requirements Head-On
Most devices entering the United States need FDA clearance. Class II products typically use the 510(k) pathway (substantial equivalence). Class III devices require Premarket Approval with significant clinical evidence.
Your U.S. partner or importer usually submits the application, but you must supply full technical support and maintain QMS compliance (including the shift toward QMSR expectations). Register your manufacturing site with the FDA where required and prepare for possible inspections. Labeling must follow U.S. rules, including Unique Device Identification (UDI) for many product categories.
Step 5: Use Available Government Incentives
Check whether your products qualify under the Production Linked Incentive (PLI) scheme for medical devices. The ₹3,420 crore program offers incentives on incremental sales for eligible high-value equipment. This improves margins and makes Indian-made devices more competitive for American buyers.
Even if your specific device isn’t covered, the overall policy push is improving infrastructure and supplier ecosystems across the country.
Step 6: Handle Logistics and Export Paperwork Professionally
Obtain an Import Export Code (IEC) from DGFT if you don’t already have one. Prepare standard shipping documents: commercial invoice, packing list, certificate of origin, and bill of lading or airway bill. A Free Sale Certificate from CDSCO can help demonstrate that your device meets Indian regulatory standards.
Work with freight forwarders experienced in temperature-sensitive or regulated medical goods. Confirm with CDSCO via the Sugam portal whether your product requires any additional Export NOC—requirements are stricter for certain drug-like or novel items.
Step 7: Set Up Post-Market Surveillance Systems
Exports continue long after the shipment leaves the dock. Establish clear processes for handling complaints, adverse event reporting, and ongoing performance monitoring. Align these with both Indian expectations and U.S. FDA Medical Device Reporting rules.
Strong post-market performance protects your brand and leads to repeat orders and long-term partnerships.
As 2026 progresses, manufacturers who treat compliance and quality as core business functions—not afterthoughts—will capture the largest share of growing U.S.–India medical device trade. Focus on building transparent relationships with American partners, delivering consistent quality, and staying current with both CDSCO updates and FDA expectations.
The opportunity is real for those willing to do the work right.
Follow us on X @realnewshubs and subscribe for push notifications